Ucb and veeva collaborate to advance the patient experience in clinical trials

Companies collaborate to set a new standard for patient-centric digital clinical trials brussels and pleasanton, calif. , may 23, 2023 /prnewswire/ -- veeva systems (nyse: veev) and ucb, a global biopharmaceutical company, today announced a collaboration that will focus on technology-driven solutions aimed at improving the patient experience and trial efficiency.
VEEV Ratings Summary
VEEV Quant Ranking